| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KIN001-135 | GDSC1000 | pan-cancer | AAC | 0.046 | 0.5 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | -0.038 | 0.5 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | 0.028 | 0.5 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.046 | 0.5 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.5 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | -0.031 | 0.5 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.5 |